Clinical and Experimental Ophthalmology

Papers
(The TQCC of Clinical and Experimental Ophthalmology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Past Lecturers and Briefs For the Named Lectures: RANZCO Annual Scientific Congress184
Continuing Professional Development85
Mimickers of hydroxychloroquine retinal toxicity69
Artificial intelligence in ophthalmology: Optimization of machine learning for ophthalmic care and research63
Issue Information47
Issue Information45
Role of chloramphenicol eye drops for endophthalmitis prophylaxis following cataract surgery: Outcomes of institutional cessation44
Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review44
Microbiological diagnosis of endophthalmitis using nanopore targeted sequencing43
Vaccination with circulating exosomes in autoimmune uveitis prevents recurrent intraocular inflammation36
Fluid misdirection syndrome associated with endothelial keratoplasty: A multicenter case series35
Improved methods for isolating the mouse retinal vasculature35
Circular RNA expression profile and functional analysis of circUvrag in light‐induced photoreceptor degeneration33
The association between keratoconus and allergic eye diseases: A systematic review and meta‐analysis31
Telemedicine and delivery of ophthalmic care in rural and remote communities: Drawing from Australian experience30
Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study27
Continuing Professional Development26
The impact of submacular fluid volume on visual outcome in macula‐off rhegmatogenous retinal detachments25
Continuing Professional Development24
Issue Information24
Sunday 27 February Speakers23
22
Issue Information21
Durability of anti‐vascular endothelial growth factor agents in neovascular age‐related macular degeneration20
20
Continuing Professional Development20
Comparison of various treatment modalities in patients with primary vitreoretinal lymphoma: A systematic review and meta‐analysis20
Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity20
Is it time to consider how we approach bilateral same‐day cataract surgery?18
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration in 2022: Same, same but different18
Global challenges in the management of diabetic retinopathy in women with pre‐gestational diabetes18
Optimised minus lens overcorrection for paediatric intermittent exotropia: A randomised clinical trial17
Gender differences in retinal diseases: A review17
‘Closing the gap’ on visual acuity outcomes of Indigenous and remote patients receiving intravitreal injections in Northern Australia17
Decreased iris thickness on swept‐source optical coherence tomography in patients with primary open‐angle glaucoma17
Publishing opportunities and gender equity: Embedding monitoring in eye health education17
Social determinants of health and health disparities in glaucoma: A review17
Management of macular oedema due to retinal vein occlusion: An evidence‐based systematic review and meta‐analysis17
Seasonal Trends in HLAB27‐Associated Uveitis: A Commentary on Recent Findings16
Seasonal Variation in HLAB27 Associated Uveitis16
Topical Dorzolamide for Macular Holes: A Randomised, Double‐Blind, Placebo‐Controlled Trial–Comment16
16
Issue Information15
Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?15
Issue Information15
Chronic Kidney Disease and Glaucoma: Is the Case Truly Closed?14
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia – Atropine for the Treatment of Myopia (WA‐ATOM) study14
Evaluation of ChatGPT‐4 responses to glaucoma patients' questions: Can artificial intelligence become a trusted advisor between doctor and patient?14
Bridging healthcare disparities in diabetic retinopathy care: Insights from Sri Lanka14
14
Environmental influences on ophthalmic conditions: A scoping review14
Randomised controlled trial on robot‐assisted versus manual surgery for pucker peeling13
Corneal endothelial evaluations in immunoglobulin g4‐related ophthalmic disease13
Long‐term limitations and complications of trans‐scleral diode laser cycloablation for refractory glaucoma13
Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia‐Specific Tools and Audience‐Oriented Approaches—Response13
Comparative study of 2‐year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery13
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances12
Corrigendum12
12
Comparison of metabolic profiles in aqueous humour of Fuchs' syndrome and presumed viral‐induced anterior uveitis patients12
EDITORIAL PROFILES12
Correction to ‘Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerance’12
Continuing Professional Development12
Monday 28 February Speakers12
Scientific Program12
Gender and country of residence of presenters in the retinal field at global ophthalmology conferences11
Dr AI will see you now11
Antimicrobial stewardship in ocular infections: Fourteen years of over‐the‐counter chloramphenicol in Australia11
Leber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices11
Insights into the diagnosis and management of sarcoid uveitis: A review11
Are There Biomechanical Changes in Tomographically Progressive Keratoconus Corneas?11
Saturday 02 November10
Keratoconus in Down syndrome: Prevalence, risk factors, severity and corneal tomographic characteristics10
Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion10
Retraction10
Predictive Factors for Uveitis Refractory to Treatment in Initial‐Onset Acute Vogt‐Koyanagi‐Harada Disease10
Biometry and corneal aberrations after cataract surgery in childhood10
Central serous chorioretinopathy: A review10
Issue Information9
Te hauora karu o te iwi Māori: A comprehensive review of Māori eye health in Aotearoa/New Zealand9
Saturday 29 October Speakers9
Editorial Profiles9
Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma9
Continuing Professional Development9
Issue Information9
AI: From productivity dividend to better patient outcome9
Outcomes of Stent Removal in Eyes With the Paul Glaucoma Implant With Intraluminal 6–0 Polypropylene8
Evaluation of ocular surface following PreserFlo Microshunt implantation: Functional outcomes and quality of life8
Evaluation of mild periorbital cellulitis and home‐based therapy in children—EPOCH study: A prospective single centre cohort study8
Retreatment interval lengthening achieved in two thirds of eyes with prolonged intensive anti‐VEGF therapy for neovascular age‐related macular degeneration after switching to faricimab8
Outcomes of cataract surgery in paediatric uveitis: A multisite study8
Longitudinal Visual Biomarkers in Dominant Optic Atrophy: A Systematic Review and Meta‐Analysis8
eFOCUS 2: A randomised crossover trial of smartphone fundoscopy and direct ophthalmoscopy aiming to improve optic disc interpretation by medical students with e‐learning support8
Utility of topical cocaine testing for the evaluation of paediatric anisocoria8
Epidemiology of monocanalicular stenting in paediatric lacrimal canalicular trauma8
Utilisation of Genetic Testing of Inherited Retinal Diseases in an Australian Public Tertiary Hospital Setting7
Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome7
Detecting Glaucoma in Highly Myopic Eyes From Fundus Photographs Using Deep Convolutional Neural Networks7
Global retinoblastoma studies: A review7
Normal‐tension glaucoma: Current concepts and approaches‐A review7
Nocturnal hypoxia and age‐related macular degeneration7
Biomarkers in age‐related macular degeneration7
Eyes Offshore: Reporting the Eye Health Needs of Refugees and Asylum Seekers in Australia's Offshore Detention Centres7
Current understanding of subclinical diabetic retinopathy informed by histology and high‐resolution in vivo imaging7
Mean macular intercapillary area in eyes with diabetic macular oedema after anti‐vascular endothelial growth factor therapy and its association with treatment response7
Ten‐year review of neuroimaging in acute paediatric strabismus7
Issue Information7
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)7
Retinal Gene Therapy: Perceptions of Ophthalmologists in Australia and New Zealand7
Evaluation of moderate periorbital cellulitis and home‐based therapy in children (EPOCH study, Part 2): A prospective single centre cohort study7
Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry7
Diabetic Retinopathy During Pregnancy: Implications of Intensive Control Prior to Pregnancy With Incretin Mimetic Therapy in Type 2 Diabetes Mellitus6
Natural history and biomarkers of KCNV2‐associated retinopathy6
One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion6
Seeking best outcomes for patients living with vitreoretinal lymphoma6
Continuing professional development6
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances: Response6
Reliability of surgical memory and self‐report in patients with prior strabismus surgery6
Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye6
Continuing Professional Development6
Poster Abstracts6
A retinal endothelial cell barrier is disrupted by direct contact with retinal Müller glial cells in vitro6
Ageing and retinal thickness: An important association6
Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease6
Evaluation of artificial intelligence models for the detection of asymmetric keratoconus eyes using Scheimpflug tomography6
The Challenge of Managing Paediatric Periorbital Cellulitis5
Low‐concentration atropine eyedrops for myopia control in a multi‐racial cohort of Australian children: A randomised clinical trial5
Issue Information5
Film Abstracts5
Real‐world outcomes of low‐dose atropine therapy on myopia progression in an Australian cohort during the COVID‐19 pandemic5
An old yet new issue: Infection of the eye5
Quality of eye care: Time to act5
Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation5
Therapeutic prognostic factors associated with retinal detachment and visual outcomes in acute retinal necrosis5
A focus on glaucoma5
5
Medical therapy for glaucoma: A review5
Past Lecturers and Briefs for the Named Lectures: RANZCO Annual Scientific Congress5
Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting5
Effect of lens status and age on ultra‐wide‐field fundus autofluorescence in eyes with granular corneal dystrophy5
Stargardt disease: Multimodal imaging: A review5
Continuing Professional Development5
Powerful predictors5
The enigma of corneal astigmatism5
Running to save sight: The effects of exercise on retinal health and function5
Corneal immune cell morphometry as an indicator of local and systemic pathology: A review5
Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial5
Retention time of different ophthalmic viscosurgical devices during phacoemulsification in rabbit ocular model: A comparative analysis4
Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis—Response4
The challenge in the diagnosis and management of vitreoretinal lymphoma4
Invited Speakers4
Continuing Professional Development4
Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study4
A novel genomic rearrangement on chr19q13.42 leads to PRPF31‐associated retinitis pigmentosa4
Invited Speakers4
Continuing Professional Development4
Association between dietary niacin and retinal nerve fibre layer thickness in healthy eyes of different ages4
Visual fields in glaucoma: Where are we now?4
Issue Information4
Association of obesity and metabolic syndrome with incident primary open angle glaucoma in the UK Biobank4
Deep learning in optical coherence tomography: Where are the gaps?4
CONTINUING PROFESSIONAL DEVELOPMENT4
The Royal Australian and New Zealand College of Ophthalmologists, 55th Annual Scientific Congress 1 – 4 November 2024Adelaide Convention Centre4
Continuing professional development4
Sustained and rebound effect of repeated low‐level red‐light therapy on myopia control: A 2‐year post‐trial follow‐up study4
4
Efficacy of oral doxycycline in the treatment of recurrent corneal erosion syndrome4
4
Film Abstracts4
4
Use of antihypertensive medications and the risk of glaucoma onset: Findings from the 45 and Up Study4
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry4
0.13888812065125